Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review
Abstract Background Health systems are often susceptible to corruption risks. Corruption within health systems has been found to negatively affect the efficacy, safety, and, significantly, equitable distribution of health products. Enforcing effective anti-corruption mechanisms is important to reduc...
Saved in:
Main Authors: | Kari A. Griffore (Author), Andrea Bowra (Author), Sara J.T. Guilcher (Author), Jillian Kohler (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
by: Jillian Clare Kohler, et al.
Published: (2020) -
The Global Fund: why anti-corruption, transparency and accountability matter
by: Zhihao Chang, et al.
Published: (2021) -
Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria
by: Jillian Clare Kohler, et al.
Published: (2020) -
An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement
by: Tim K. Mackey, et al.
Published: (2020) -
Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches
by: Taryn Vian
Published: (2020)